The company will receive technology transfer from Gilead for manufacturing of the drug, it added.
Dr Reddy's would need to scale up manufacturing and obtain regulatory approval for marketing of this drug in respective countries, the company said.
Remdesivir, an investigational antiviral therapy developed by Gilead, has received Emergency Use Authorisation (EUA) by the US Food and Drug Administration (USFDA) to treat COVID-19.
SEE ALSO:
$4
$4
$4